Announcements Trials
Browse Landscape

Status

Completed 1

Sponsor Class

INDUSTRY 1

Study Type

Interventional 15Observational 1

Sponsor

Cancer Type

Classical hematology 1

Conditions

Venous Thrombosis 1Venous Thromboembolism 1Pulmonary Embolism 1Neoplasms 1Acute Deep Vein Thrombosis 1

Interventions

Rivaroxaban 5apixaban 4Heparin, Low-Molecular-Weight 2Dabigatran 2ribociclib 1palbociclib 1edoxaban 1calcium heparin 1abemaciclib 1Tinzaparin 1Surveys and Questionnaires 1Observation 1Nadroparin 1Mass Screening 1Heparin 1Fondaparinux 1Enoxaparin 1Data Collection 1Dalteparin 1Anticoagulants 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Observational × Venous Thromboembolism × Dalteparin × Clear all
NCT01444612 2017-05-16

Comparative Analysis of Injectable Anticoagulants for Thromboprophylaxis Post Cancer-related Surgery

GlaxoSmithKline

Completed
4,068 enrolled
Classical hematology

Venous Thrombosis, Venous Thromboembolism

Data powered by HemOnc (CC BY 4.0) Colophon âš¡